Cargando...
Overview and Management of Cardiac Adverse Events Associated With Tyrosine Kinase Inhibitors
BACKGROUND. Small-molecule tyrosine kinase inhibitors (TKIs) may provide an effective therapeutic option in patients with hematologic malignancies and solid tumors. However, cardiovascular (CV) events, including hypertension, heart failure, left ventricular systolic dysfunction, and QT prolongation,...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AlphaMed Press
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3755926/ https://ncbi.nlm.nih.gov/pubmed/23918069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0466 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|